SE7609443L - Sett att framstella ett stabilt farmaceutiskt preparat - Google Patents

Sett att framstella ett stabilt farmaceutiskt preparat

Info

Publication number
SE7609443L
SE7609443L SE7609443A SE7609443A SE7609443L SE 7609443 L SE7609443 L SE 7609443L SE 7609443 A SE7609443 A SE 7609443A SE 7609443 A SE7609443 A SE 7609443A SE 7609443 L SE7609443 L SE 7609443L
Authority
SE
Sweden
Prior art keywords
produce
way
pharmaceutical preparation
stable pharmaceutical
amino acid
Prior art date
Application number
SE7609443A
Other languages
Unknown language ( )
English (en)
Other versions
SE439586B (sv
Inventor
I Sugimoto
Y Sawase
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50108197A external-priority patent/JPS5231821A/ja
Priority claimed from JP8061376A external-priority patent/JPS537662A/ja
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of SE7609443L publication Critical patent/SE7609443L/sv
Publication of SE439586B publication Critical patent/SE439586B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE7609443A 1975-09-05 1976-08-26 Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat SE439586B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50108197A JPS5231821A (en) 1975-09-05 1975-09-05 Method of manufacturing freeze-dried dehydroepiandrosterone sulfate sa lts for injection use
JP8061376A JPS537662A (en) 1976-07-06 1976-07-06 Preparation of injection containing stable dehydroepiandrosterone sulfate

Publications (2)

Publication Number Publication Date
SE7609443L true SE7609443L (sv) 1977-03-06
SE439586B SE439586B (sv) 1985-06-24

Family

ID=26421606

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609443A SE439586B (sv) 1975-09-05 1976-08-26 Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat

Country Status (15)

Country Link
US (1) US4061744A (sv)
AU (1) AU498543B2 (sv)
CA (1) CA1047404A (sv)
CS (1) CS216160B2 (sv)
DD (1) DD127381A5 (sv)
DE (1) DE2639849C2 (sv)
DK (1) DK153124C (sv)
ES (1) ES451256A1 (sv)
FR (1) FR2322605A1 (sv)
GB (1) GB1561360A (sv)
HU (1) HU173475B (sv)
IL (1) IL50376A (sv)
NL (1) NL183385C (sv)
SE (1) SE439586B (sv)
SU (1) SU1072789A3 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
US5246704A (en) * 1989-01-23 1993-09-21 Kanebo, Ltd. Vaginal suppository
JP2546808B2 (ja) * 1989-01-23 1996-10-23 鐘紡株式会社 膣坐剤
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
CA2013474C (en) * 1989-04-20 2000-01-18 Pharmacia Inc. Cyclophosphamide - alanine lyophilizates
US5268368A (en) * 1991-05-17 1993-12-07 Erbamont, Inc. Cyclophosphamide--amino acid lyophilizates
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957392A (en) * 1961-07-17 1964-05-06 Farmaceutici Italia 16ª‡-hydroxy-steroids
DE1767898A1 (de) * 1967-07-28 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung einer Arzneimittelzubereitung
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin

Also Published As

Publication number Publication date
SU1072789A3 (ru) 1984-02-07
GB1561360A (en) 1980-02-20
IL50376A (en) 1979-10-31
CS216160B2 (en) 1982-10-29
SE439586B (sv) 1985-06-24
FR2322605B1 (sv) 1982-08-20
CA1047404A (en) 1979-01-30
NL183385C (nl) 1988-10-17
DK396576A (da) 1977-03-06
AU498543B2 (en) 1979-03-15
DK153124B (da) 1988-06-20
HU173475B (hu) 1979-05-28
US4061744A (en) 1977-12-06
NL7609833A (nl) 1977-03-08
DD127381A5 (sv) 1977-09-21
DE2639849A1 (de) 1977-03-17
DE2639849C2 (de) 1987-02-12
IL50376A0 (en) 1976-10-31
NL183385B (nl) 1988-05-16
ES451256A1 (es) 1977-09-16
FR2322605A1 (fr) 1977-04-01
AU1748676A (en) 1978-03-16
DK153124C (da) 1988-12-19

Similar Documents

Publication Publication Date Title
FR2437406A1 (fr) Derives d'acide quinoleinecarboxylique substitue et leur utilisation comme agents antibacteriens
DK579875A (da) Aminosyrepreparater
ZA754167B (en) Sulphonic acid salts of s-adenosilmethionine, process for the preparation thereof and therapeutic compositions containing them
JPS559023A (en) Production of dopa preparation in high concentration
SE7904118L (sv) Sett att framstella en urokinaskomposition
NL155264B (nl) Werkwijze voor de bereiding van een in water onoplosbaar chelaat van een biologisch werkzaam aminozuur, zuuramide of aminoglycoside, alsmede een geheel of gedeeltelijk uit zo'n onoplosbaar chelaat bestaand gevormd voortbrengsel.
ES451256A1 (es) Un metodo para producir una preparacion farmaceutica establepara administracion parenteral.
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
JPS51146432A (en) Process for preparation of benzanilide derivatives having therapeutic action to immunological disease
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
GR37361B (el) Μεθοδος δια την παρασκευην παραγωγων του διαρυλοκυκλοπροπανιου.
FI56770B (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart stabilt fast kolinsalicylatkomplex
SE428468B (sv) Sett att framstella 3,3'-triarylmetandikarboxylsyraderivat
JPS5661369A (en) Inclusion compound of thialamide or its acid addition salt
ES391536A1 (es) Procedimiento para la obtencion de composiciones antibacte-riales.
AT349458B (de) Verfahren zur herstellung von n-(1-aethyl-2- pyrrolidinylmethyl)-2-methoxy-5-sulfamoyl- benzamid, von dessen saeureadditions- sowie von dessen quartaeren ammoniumsalzen
FI803305A7 (sv) Förfarande för framställning av nya sulfonsyracykloalkylamider och deras användning såsom mikrobicider.
GB1111563A (en) Methods for preparing n-benzyl-n',n"-dimethylguanidine
ES450129A1 (es) Procedimiento para la preparacion de fluorhidrato de 3-piri-dil-metanol.
GB1468116A (en) Esters of 5-n-butyl-pyridine-2-carboxylic acid
BG34763A3 (bg) Метод за получаване на виндезинов сулфат
GB916284A (en) Flavouring and preparation thereof
IT1047638B (it) Procedimento di preparazione di acidi imminodiacetici n sostituiti composti ottenuti in tal modo e loro applicazioni come agenti chelatanti
JPS5625115A (en) Immunoglobulin composition
GB1093971A (en) Improvements in novel mercury compound

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7609443-2

Format of ref document f/p: F